These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 17194546
21. No release of histamine and substance P in capsaicin-induced neurogenic inflammation in intact human skin in vivo: a microdialysis study. Petersen LJ, Winge K, Brodin E, Skov PS. Clin Exp Allergy; 1997 Aug; 27(8):957-65. PubMed ID: 9291295 [Abstract] [Full Text] [Related]
22. The use of botulinum toxin in the pelvic floor for women with chronic pelvic pain-a new answer to old problems? Abbott J. J Minim Invasive Gynecol; 2009 Aug; 16(2):130-5. PubMed ID: 19167273 [Abstract] [Full Text] [Related]
23. Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilatation in humans. Simone DA, Ochoa J. Pain; 1991 Dec; 47(3):285-294. PubMed ID: 1784499 [Abstract] [Full Text] [Related]
24. Viscero-somatic reflexes in referred pain areas evoked by capsaicin stimulation of the human gut. Arendt-Nielsen L, Schipper KP, Dimcevski G, Sumikura H, Krarup AL, Giamberardino MA, Drewes AM. Eur J Pain; 2008 Jul; 12(5):544-51. PubMed ID: 17977761 [Abstract] [Full Text] [Related]
25. Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction. Pannek J, Göcking K, Bersch U. BJU Int; 2009 Nov; 104(9):1246-50. PubMed ID: 19426192 [Abstract] [Full Text] [Related]
27. Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain. Bach-Rojecky L, Lacković Z. Croat Med J; 2005 Apr; 46(2):201-8. PubMed ID: 15849840 [Abstract] [Full Text] [Related]
31. Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. Chuang YC, Yoshimura N, Huang CC, Wu M, Chiang PH, Chancellor MB. J Urol; 2008 Aug; 180(2):742-8. PubMed ID: 18554636 [Abstract] [Full Text] [Related]
32. Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it? da Silva CM, Cruz F. Curr Opin Urol; 2009 Jul; 19(4):347-52. PubMed ID: 19444121 [Abstract] [Full Text] [Related]
33. The effects of repeated dermal application of capsaicin to the human skin on pain and vasodilatation induced by intradermal injection of acid and hypertonic solutions. Del Bianco E, Geppetti P, Zippi P, Isolani D, Magini B, Cappugi P. Br J Clin Pharmacol; 1996 Jan; 41(1):1-6. PubMed ID: 8824686 [Abstract] [Full Text] [Related]
34. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007 Jan; 26 Suppl 1():3-106. PubMed ID: 17365137 [Abstract] [Full Text] [Related]
35. Transient cold pain has no effect on cutaneous vasodilatation induced by capsaicin: a randomized-control-crossover study in healthy subjects. Pud D, Andersen OK, Arendt-Nielsen L, Yarnitsky D. Pflugers Arch; 2006 May; 452(2):208-12. PubMed ID: 16328453 [Abstract] [Full Text] [Related]
37. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study. Ascher B, Rzany BJ, Grover R. Dermatol Surg; 2009 Oct 28; 35(10):1478-86. PubMed ID: 19686365 [Abstract] [Full Text] [Related]
38. Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction. Kitamura Y, Matsuka Y, Spigelman I, Ishihara Y, Yamamoto Y, Sonoyama W, Kamioka H, Yamashiro T, Kuboki T, Oguma K. Neuroscience; 2009 Apr 10; 159(4):1422-9. PubMed ID: 19409226 [Abstract] [Full Text] [Related]
39. The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment. Rubin MG, Dover J, Glogau RG, Goldberg DJ, Goldman MP, Schlessinger J. J Drugs Dermatol; 2009 May 10; 8(5):439-44. PubMed ID: 19537366 [Abstract] [Full Text] [Related]
40. Decreased cutaneous sensory axon-reflex vasodilatation below the lesion in patients with complete spinal cord injury. Kuesgen B, Frankel HL, Anand P. Somatosens Mot Res; 2002 May 10; 19(2):149-52. PubMed ID: 12088389 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]